Terns Pharmaceuticals Inc (NASDAQ: TERN) kicked off on Monday, up 5.70% from the previous trading day, before settling in for the closing price of $4.56. Over the past 52 weeks, TERN has traded in a range of $3.26-$14.04.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -20.00%. While this was happening, its average annual earnings per share was recorded -9.26%. With a float of $41.12 million, this company’s outstanding shares have now reached $64.58 million.
Let’s determine the extent of company efficiency that accounts for 66 employees.
Terns Pharmaceuticals Inc (TERN) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Terns Pharmaceuticals Inc is 36.39%, while institutional ownership is 76.31%. The most recent insider transaction that took place on Apr 03 ’24, was worth 856,009. In this transaction 10% Owner of this company sold 138,066 shares at a rate of $6.20, taking the stock ownership to the 268,573 shares. Before that another transaction happened on Apr 02 ’24, when Company’s 10% Owner sold 101,480 for $6.65, making the entire transaction worth $674,842. This insider now owns 272,722 shares in total.
Terns Pharmaceuticals Inc (TERN) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2023, the organization reported -$0.29 earnings per share (EPS), higher than consensus estimate (set at -$0.29) by $0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -9.26% per share during the next fiscal year.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators
Take a look at Terns Pharmaceuticals Inc’s (TERN) current performance indicators. Last quarter, stock had a quick ratio of 22.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.27, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.40 in one year’s time.
Technical Analysis of Terns Pharmaceuticals Inc (TERN)
Looking closely at Terns Pharmaceuticals Inc (NASDAQ: TERN), its last 5-days average volume was 0.7 million, which is a drop from its year-to-date volume of 0.87 million. As of the previous 9 days, the stock’s Stochastic %D was 24.78%. Additionally, its Average True Range was 0.46.
During the past 100 days, Terns Pharmaceuticals Inc’s (TERN) raw stochastic average was set at 19.92%, which indicates a significant decrease from 21.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 66.47% in the past 14 days, which was lower than the 87.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.58, while its 200-day Moving Average is $5.96. However, in the short run, Terns Pharmaceuticals Inc’s stock first resistance to watch stands at $4.95. Second resistance stands at $5.09. The third major resistance level sits at $5.33. If the price goes on to break the first support level at $4.58, it is likely to go to the next support level at $4.34. Now, if the price goes above the second support level, the third support stands at $4.21.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Key Stats
The company with the Market Capitalisation of 311.61 million has total of 64,652K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -90,210 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -21,020 K.
